Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency

Background Allan-Herndon-Dudley syndrome (AHDS)/monocarboxylate transporter 8 (MCT8) deficiency is a rare X-linked encephalopathy caused by SLC16A2 variants, impairing thyroid hormone (TH) transport into the brain. This leads to early central nervous system (CNS) TH deficiency, affecting brain matur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Bruschi, Fabio (VerfasserIn) , Vaia, Ylenia (VerfasserIn) , Antonello, Clara E. (VerfasserIn) , Spada, Marco (VerfasserIn) , Porta, Francesco (VerfasserIn) , Marinaccio, Cristina (VerfasserIn) , Carducci, Claudia (VerfasserIn) , Opladen, Thomas (VerfasserIn) , Sartorelli, Jacopo (VerfasserIn) , Zibordi, Federica Maria (VerfasserIn) , Ghezzi, Daniele (VerfasserIn) , Nicita, Francesco (VerfasserIn) , Tonduti, Davide (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 27 October 2025
In: Movement disorders
Year: 2025, Pages: 1-6
ISSN:1531-8257
DOI:10.1002/mds.70093
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/mds.70093
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.70093
Volltext
Verfasserangaben:Fabio Bruschi, MD, Ylenia Vaia, MD, Clara E. Antonello, PT, Marco Spada, MD, Francesco Porta, MD, PhD,Cristina Marinaccio, MD, Claudia Carducci, MSc, PhD, Thomas Opladen, MD, PhD, Jacopo Sartorelli, MD, Federica Maria Zibordi, MD, Daniele Ghezzi, MSc, PhD, Francesco Nicita, MD, PhD, and Davide Tonduti, MD, PhD

MARC

LEADER 00000naa a22000002c 4500
001 1946049824
003 DE-627
005 20251215113418.0
007 cr uuu---uuuuu
008 251215s2025 xx |||||o 00| ||eng c
024 7 |a 10.1002/mds.70093  |2 doi 
035 |a (DE-627)1946049824 
035 |a (DE-599)KXP1946049824 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Bruschi, Fabio  |e VerfasserIn  |0 (DE-588)1384377522  |0 (DE-627)1946050717  |4 aut 
245 1 0 |a Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency  |c Fabio Bruschi, MD, Ylenia Vaia, MD, Clara E. Antonello, PT, Marco Spada, MD, Francesco Porta, MD, PhD,Cristina Marinaccio, MD, Claudia Carducci, MSc, PhD, Thomas Opladen, MD, PhD, Jacopo Sartorelli, MD, Federica Maria Zibordi, MD, Daniele Ghezzi, MSc, PhD, Francesco Nicita, MD, PhD, and Davide Tonduti, MD, PhD 
246 3 0 |a eight 
264 1 |c 27 October 2025 
300 |b Illustrationen 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Zuerst veröffentlicht: 27. Oktober 2025 
500 |a Gesehen am 15.12.2025 
520 |a Background Allan-Herndon-Dudley syndrome (AHDS)/monocarboxylate transporter 8 (MCT8) deficiency is a rare X-linked encephalopathy caused by SLC16A2 variants, impairing thyroid hormone (TH) transport into the brain. This leads to early central nervous system (CNS) TH deficiency, affecting brain maturation. Dopaminergic circuit involvement is suggested by both pathophysiology and clinical features, reminiscent of infantile parkinsonism. Objective This study investigates dopamine metabolism and levodopa/carbidopa response in MCT8 patients. Methods We retrospectively and prospectively collected clinical, genetic, and neuroimaging data, performed cerebrospinal fluid (CSF) biogenic amine analyses, and conducted neurological assessments before and after the levodopa trial (10 mg/kg/day). Results Ten patients exhibited developmental delay, spasticity, and infantile parkinsonism. CSF analysis showed reduced homovanillic acid in 3/10 patients, with 7/10 in the lowest quartile. Levodopa improved parkinsonism and reactivity in 7/10 patients. Conclusions Our findings confirm dopaminergic involvement in AHDS and show that levodopa/carbidopa effectively treats extrapyramidal symptoms. Further investigations could differentiate presynaptic and postsynaptic defects to optimize dopaminergic therapy. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. 
650 4 |a Allan-Herndon-Dudley syndrome 
650 4 |a dystonia 
650 4 |a hypothyroidism 
650 4 |a MCT8 
650 4 |a neurotransmitter 
650 4 |a parkinsonism 
650 4 |a SLC16A2 
700 1 |a Vaia, Ylenia  |e VerfasserIn  |4 aut 
700 1 |a Antonello, Clara E.  |e VerfasserIn  |4 aut 
700 1 |a Spada, Marco  |e VerfasserIn  |4 aut 
700 1 |a Porta, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Marinaccio, Cristina  |e VerfasserIn  |4 aut 
700 1 |a Carducci, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Opladen, Thomas  |d 1974-  |e VerfasserIn  |0 (DE-588)124489656  |0 (DE-627)642820481  |0 (DE-576)335321291  |4 aut 
700 1 |a Sartorelli, Jacopo  |e VerfasserIn  |4 aut 
700 1 |a Zibordi, Federica Maria  |e VerfasserIn  |4 aut 
700 1 |a Ghezzi, Daniele  |e VerfasserIn  |4 aut 
700 1 |a Nicita, Francesco  |e VerfasserIn  |4 aut 
700 1 |a Tonduti, Davide  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Movement disorders  |d New York, NY : Wiley, 1986  |g (2025), Seite 1-6  |h Online-Ressource  |w (DE-627)326179658  |w (DE-600)2041249-6  |w (DE-576)094427003  |x 1531-8257  |7 nnas  |a Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency 
773 1 8 |g year:2025  |g pages:1-6  |g extent:6  |a Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency 
856 4 0 |u https://doi.org/10.1002/mds.70093  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.70093  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251215 
993 |a Article 
994 |a 2025 
998 |g 124489656  |a Opladen, Thomas  |m 124489656:Opladen, Thomas  |d 910000  |d 910500  |d 50000  |e 910000PO124489656  |e 910500PO124489656  |e 50000PO124489656  |k 0/910000/  |k 1/910000/910500/  |k 0/50000/  |p 8 
999 |a KXP-PPN1946049824  |e 4828045465 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"title":[{"title_sort":"Movement disorders","title":"Movement disorders","subtitle":"official journal of the Movement Disorder Society"}],"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"1986-","publisher":"Wiley","publisherPlace":"New York, NY","dateIssuedKey":"1986"}],"language":["eng"],"disp":"Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiencyMovement disorders","id":{"doi":["10.1002/(ISSN)1531-8257"],"issn":["1531-8257"],"eki":["326179658"],"zdb":["2041249-6"]},"corporate":[{"display":"Movement Disorder Society","roleDisplay":"Herausgebendes Organ","role":"isb"}],"recId":"326179658","part":{"text":"(2025), Seite 1-6","extent":"6","year":"2025","pages":"1-6"},"note":["Gesehen am 13.03.2014"],"pubHistory":["1.1986 -"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"id":{"doi":["10.1002/mds.70093"],"eki":["1946049824"]},"name":{"displayForm":["Fabio Bruschi, MD, Ylenia Vaia, MD, Clara E. Antonello, PT, Marco Spada, MD, Francesco Porta, MD, PhD,Cristina Marinaccio, MD, Claudia Carducci, MSc, PhD, Thomas Opladen, MD, PhD, Jacopo Sartorelli, MD, Federica Maria Zibordi, MD, Daniele Ghezzi, MSc, PhD, Francesco Nicita, MD, PhD, and Davide Tonduti, MD, PhD"]},"origin":[{"dateIssuedDisp":"27 October 2025","dateIssuedKey":"2025"}],"physDesc":[{"extent":"6 S.","noteIll":"Illustrationen"}],"language":["eng"],"person":[{"family":"Bruschi","display":"Bruschi, Fabio","given":"Fabio","roleDisplay":"VerfasserIn","role":"aut"},{"family":"Vaia","display":"Vaia, Ylenia","given":"Ylenia","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Clara E.","role":"aut","roleDisplay":"VerfasserIn","display":"Antonello, Clara E.","family":"Antonello"},{"given":"Marco","roleDisplay":"VerfasserIn","role":"aut","display":"Spada, Marco","family":"Spada"},{"display":"Porta, Francesco","role":"aut","roleDisplay":"VerfasserIn","given":"Francesco","family":"Porta"},{"given":"Cristina","role":"aut","roleDisplay":"VerfasserIn","display":"Marinaccio, Cristina","family":"Marinaccio"},{"family":"Carducci","given":"Claudia","roleDisplay":"VerfasserIn","role":"aut","display":"Carducci, Claudia"},{"family":"Opladen","display":"Opladen, Thomas","given":"Thomas","role":"aut","roleDisplay":"VerfasserIn"},{"family":"Sartorelli","roleDisplay":"VerfasserIn","role":"aut","given":"Jacopo","display":"Sartorelli, Jacopo"},{"family":"Zibordi","display":"Zibordi, Federica Maria","given":"Federica Maria","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Daniele","display":"Ghezzi, Daniele","family":"Ghezzi"},{"family":"Nicita","display":"Nicita, Francesco","given":"Francesco","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","given":"Davide","display":"Tonduti, Davide","family":"Tonduti"}],"title":[{"title_sort":"Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency","title":"Altered dopamine metabolism and response to treatment with Levodopa/Carbidopa in MCT8 deficiency"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1946049824","note":["Zuerst veröffentlicht: 27. Oktober 2025","Gesehen am 15.12.2025"]} 
SRT |a BRUSCHIFABALTEREDDOP2720